New on F1000Research – 2 March 2015
2 March, 2015 | Eva Amsen |
|
|
A selection of new content on F1000Research from the past week. To receive notification of all new articles, sign up for our table of contents alerts.
Featured Referee Report
Since our refereeing is open and transparent, we can feature some of the great comments we get. This is a quote from a referee report by Stephen Groft, from the Office of Rare Diseases Research, National Institutes of Health on Ekins et al.’s article about collaboration for rare disease drug discovery research:
“This is a very well referenced opinion article on rare diseases and orphan products including historical and current activities that have led to an increased global emphasis on rare diseases research and orphan products development.”
Newly published articles
We published a lot of new articles last week. Here’s a selection. Note that they are all still awaiting peer review. If you would like to follow the progress of any article through the review and revision tages, you can click “track” from any of the article pages.
The role of globalization in drug development and access to orphan drugs: orphan drug legislation in the US/EU and in Latin America [v1; ref status: awaiting peer review, https://f1000r.es/3ix]
Renée J.G. Arnold, Lida Bighash, Alejandro Bryón Nieto, Gabriela Tannus Branco de Araújo, Juan Gabriel Gay-Molina, Federico Augustovski
In vitro retention of a new thermoplastic titratable mandibular advancement device [v1; ref status: awaiting peer review, https://f1000r.es/509]
Marc Braem
Theoretical modelling of epigenetically modified DNA sequences [v1; ref status: awaiting peer review, https://f1000r.es/531]
Alexandra Teresa Pires Carvalho, Maria Leonor Gouveia, Charan Raju Kanna, Sebastian K. T. S. Wärmländer, Jamie Platts, Shina Caroline Lynn Kamerlin
|